FARO ECONÓMICOSTOCK ANALYSIS

CORT — analysis and forecast

$74.30-0.3% todayCorcept Therapeutics Incorporated
Verdict
Bearish
RSI (14)
29
MACD
▼ falling
Trend
Downtrend
Volatility
71%
52w range
46%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

81/ 100
Strong multibagger DNA

Strongest: Business quality and Price vs. growth. Most lacking: Cash it generates and Faro seal.

Room to grow82

Worth $8.1 B. To grow ×10 it would have to reach $81.3 B.

Sales engine86

Sales +64% last quarter (year over year) and +13% last fiscal year · accelerating.

Business quality100

Gross margin 99%, operating margin 12%, return on equity 22%.

Cash it generates52

Free cash flow $132 M a year = 1.6% of its value.

Price vs. growth94

Trades at 8.4× sales: 0.22 per point of growth (lower is better).

Balance sheet89

Net cash equal to 4% of its value.

Faro seal65

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 11.3%.

⏱️ Timing (not scored): mid-range over 12 months (47%) · below its 200-day average · trailing the S&P 500 by 15 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayStrongly bearish40%$74.33 +0.1%$71.08 – $77.74
3 daysStrongly bearish40%$74.41 +0.2%$68.85 – $80.41
1 weekStrongly bearish40%$74.48 +0.3%$67.39 – $82.32
15 daysBearish41%$74.67 +0.5%$64.81 – $86.03
1 monthBearish42%$75.08 +1.1%$61.15 – $92.18
3 monthsBearish44%$76.68 +3.2%$53.74 – $109.40

Recent momentum: -34.5% over 20 days · -37.6% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for CORT. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 34 for $25 — included in Navigator and Admiral.

See all 34 reports →

❓ Frequently asked questions about CORT

Could CORT be the next NVIDIA?

Its Faro multibagger DNA is 81/100 (strong multibagger dna): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has CORT fallen in the last year?

Corcept Therapeutics (CORT) is down 6.0% over the last 12 months and trades at $74.30, 39.9% below its 52-week high ($123.57). 52-week range: $32.15 – $123.57.

How volatile is CORT stock?

Its annualized volatility is around 71% and its worst drop from a peak over the last year was 63.5%. For reference, the S&P 500 usually moves 15–20% a year.

Does CORT have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy CORT?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: bearish technical bias, RSI 29 (oversold zone), price below its 50-day average and an estimated 42% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.